These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17467265)

  • 21. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma.
    Demizu Y; Sasaki R; Soejima T; Maruta T; Okamoto Y; Yamada K; Yoden E; Ejima Y; Ota Y; Ishida H; Nibu K; Sugimura K
    Jpn J Clin Oncol; 2006 Oct; 36(10):620-5. PubMed ID: 16905756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Concomitant chemo-radiotherapy for locoregionally advanced nasopharygeal carcinoma].
    Tian Y; Chua DT; Sham JS
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):429-31. PubMed ID: 16188131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
    Kong L; Hu C; Niu X; Zhang Y; Guo Y; Tham IW; Lu JJ
    Cancer; 2013 Dec; 119(23):4111-8. PubMed ID: 24037893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
    Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL
    Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone.
    Chua DT; Sham JS; Choy DT
    Cancer; 2004 Jul; 101(2):307-16. PubMed ID: 15241828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.
    Low WK; Toh ST; Wee J; Fook-Chong SM; Wang DY
    J Clin Oncol; 2006 Apr; 24(12):1904-9. PubMed ID: 16622266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
    Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
    Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma.
    Daoud J; Toumi N; Siala W; Ghorbel A; Drira MM; Frikha M
    Radiother Oncol; 2007 Oct; 85(1):17-23. PubMed ID: 17343938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
    Aravantinos G; Fountzilas G; Bamias A; Grimani I; Rizos S; Kalofonos HP; Skarlos DV; Economopoulos T; Kosmidis PA; Stathopoulos GP; Briasoulis E; Pectasides D; Samantas E; Timotheadou E; Papadimitriou C; Papanikolaou A; Onyenadum A; Papakostas P; Bafaloukos D; Dimopoulos MA;
    Eur J Cancer; 2008 Oct; 44(15):2169-77. PubMed ID: 18691879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients.
    Otty Z; Skinner MB; Dass J; Collins M; Mooi J; Thuraisingam K; Sabesan S
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):287-92. PubMed ID: 21884441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: preliminary results.
    Veerasarn V; Lorvidhaya V; Kamnerdsupaphon P; Suntornpong N; Sangruchi S; Lertsanguansinchai P; Khorprasert C; Sookpreedee L; Udompunturak S
    Gynecol Oncol; 2007 Jan; 104(1):15-23. PubMed ID: 16996583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperfractionated radiation therapy for locoregionally advanced nasopharyngeal cancer.
    Isobe K; Uno T; Kawakami H; Ueno N; Aruga T; Yasuda S; Hanazawa T; Okamoto Y; Ito H; Shigematsu N
    Jpn J Clin Oncol; 2005 Mar; 35(3):116-20. PubMed ID: 15741300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
    Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
    Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcome of locally advanced nasopharyngeal cancer with concurrent chemoradiotherapy.
    Yarney J; Vanderpuye V; Kitcher ED
    West Afr J Med; 2008 Apr; 27(2):65-8. PubMed ID: 19025016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.
    Kwong DL; Sham JS; Au GK; Chua DT; Kwong PW; Cheng AC; Wu PM; Law MW; Kwok CC; Yau CC; Wan KY; Chan RT; Choy DD
    J Clin Oncol; 2004 Jul; 22(13):2643-53. PubMed ID: 15226332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT.
    Möbus V; Wandt H; Frickhofen N; Bengala C; Champion K; Kimmig R; Ostermann H; Hinke A; Ledermann JA; ;
    J Clin Oncol; 2007 Sep; 25(27):4187-93. PubMed ID: 17698804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
    Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW
    Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.